These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36576324)

  • 1. Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease.
    Sakon C; Nikirk M; O'Brien ARW
    Expert Rev Hematol; 2023 Feb; 16(2):147-150. PubMed ID: 36576324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients.
    Davila J; Stanek J; O'Brien SH
    Blood Adv; 2023 May; 7(9):1762-1768. PubMed ID: 37103974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One Size Does Not Fit All: Venous Thromboembolism Prophylaxis in Colorectal Cancer.
    Perrotti G; Sadri L; Fassler M; Sharma D; Kim S; Zebley M; Fassler S
    JSLS; 2020; 24(3):. PubMed ID: 32831542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients.
    Ionescu F; Anusim N; Zimmer M; Jaiyesimi I
    Eur J Haematol; 2022 Sep; 109(3):282-288. PubMed ID: 35617049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late venous thromboembolism prophylaxis after craniotomy in acute traumatic brain injury.
    Daley MJ; Ali S; Brown CV
    Am Surg; 2015 Feb; 81(2):207-11. PubMed ID: 25642886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects in Processes of Care for Pharmacologic Prophylaxis Are Common Among Neurosurgery Patients Who Develop In-Hospital Postoperative Venous Thromboembolism.
    Yun R; Sciubba DM; Lewin JJ; Streiff MB; Haut ER; Lau BD; Shermock KM; Kraus PS; Popoola VO; Dalpoas SE
    World Neurosurg; 2020 Feb; 134():e664-e671. PubMed ID: 31698120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Postoperative Venous Thromboembolism in Thoracic Surgical Patients: Implementation and Evaluation of a Caprini Risk Assessment Protocol.
    Hachey KJ; Sterbling H; Choi DS; Pinjic E; Hewes PD; Munoz J; McAneny D; Tripodis Y; Fernando HC; Litle VR
    J Am Coll Surg; 2016 Jun; 222(6):1019-27. PubMed ID: 26775163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.
    Naik RP; Streiff MB; Lanzkron S
    J Thromb Thrombolysis; 2013 Apr; 35(3):352-8. PubMed ID: 23435703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies.
    Shermock KM; Lau BD; Haut ER; Hobson DB; Ganetsky VS; Kraus PS; Efird LE; Lehmann CU; Pinto BL; Ross PA; Streiff MB
    PLoS One; 2013; 8(6):e66311. PubMed ID: 23799091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis.
    Di Mauro AL; Austin LJ; Zande J; Winckel K; Neale R; De Guzman KR
    Blood Coagul Fibrinolysis; 2024 Apr; 35(3):101-107. PubMed ID: 38358899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients.
    Walker CK; Sandmann EA; Horyna TJ; Gales MA
    Ann Pharmacother; 2017 Apr; 51(4):323-331. PubMed ID: 28228055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective Evaluation of Venous Thromboembolism Prophylaxis in Elderly, High-Risk Trauma Patients.
    Krantz EN; Philpott CD; Droege ME; Mueller EW; Ernst NE; Garber PM; Tsuei BJ; Goodman MD; Droege CA
    J Surg Res; 2020 May; 249():225-231. PubMed ID: 31991331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of High-Dose Unfractionated Heparin Versus High-Dose Enoxaparin for Venous Thromboembolism Prevention in Morbidly Obese Hospitalized Patients.
    Mason SW; Barber A; Jones E; Chen SL; Moll S; Northam K
    Am J Med; 2020 Jun; 133(6):e249-e259. PubMed ID: 31862336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effectiveness of venous thromboembolism prophylaxis with enoxaparin between obese and non-obese patients.
    Alnatsheh AH; Beckett RD; Waterman S
    J Oncol Pharm Pract; 2019 Jun; 25(4):813-817. PubMed ID: 29486637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two pharmacological prophylaxis strategies for venous thromboembolism in spinal cord injury patients: a retrospective study.
    de Almeida RL; Rodrigues CC; Melo E Silva CA; Beraldo PSS; Amado VM
    Spinal Cord; 2019 Oct; 57(10):890-896. PubMed ID: 31101899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of oral anticoagulants in patients with sickle cell disease and venous thromboembolism: a retrospective cohort study.
    Roberts MZ; Gaskill GE; Kanter-Washko J; Kyle TR; Jones BC; Bohm NM
    J Thromb Thrombolysis; 2018 May; 45(4):512-515. PubMed ID: 29556958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
    Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
    J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
    Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
    Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
    Marciniak CM; Kaplan J; Welty L; Chen D
    PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.